文献速递心律失常

美国确诊房颤最低全国患病率:基于加州急性护理机构数据的推算

Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities.
PubMed 文献 · J Am Coll Cardiol · 2024-09-11

该研究合并加州全州医疗数据库,纳入2005至2019年接受医院诊疗的29,250,310名成人,用ICD编码识别房颤,经年龄、性别、种族标准化推算美国确诊房颤患病率。结果显示加州队列中6.8%有房颤诊断,患病比例从2005至2009年的4.49%升至2015至2019年的6.82%,推算当前美国确诊房颤至少10.55百万人,占成人的4.48%。

要点

  • 加州2005–2019年医院诊疗成人中6.8%有房颤诊断,患病比例由4.49%升至6.82%。
  • 推算美国确诊房颤至少10.55百万人,占成人4.48%,高于既往估计。
  • 房颤患者趋向相对年轻、女性和白人比例下降,高血压和糖尿病更多。

核心结论

  • 美国确诊房颤的患病率高于既往估计,需更有效的预防和治疗策略以减轻房颤负担。

研究设计与样本

  • 研究合并加州全州医疗数据库,构建2005至2019年接受医院诊疗的20岁及以上成人队列,共29,250,310人,平均年龄50.6±19.8岁,53.8%为女性,50.1%为白人。
  • 使用国际疾病分类编码识别房颤及其他合并症,并考虑死亡后利用美国人口普查数据计算全国年龄、性别、种族标准化的确诊房颤估计值。

主要发现

  • 29,250,310名患者中2,003,867人(6.8%)有房颤诊断。
  • 有房颤诊断的患者比例从2005至2009年的4.49%上升至2015至2019年的6.82%。
  • 随时间推移,房颤患者相对更年轻,女性或白人比例更低,高血压和糖尿病比例更高。
  • 按年龄、性别、种族和族裔比例标准化至美国人口,估计当前全国确诊房颤患病率至少为10.55百万人(95%CI:10.48–10.62百万),占成人人口的4.48%(95%CI:4.47%–4.49%)。

临床怎么用

  • 临床与公共卫生层面应认识到美国确诊房颤负担高于既往估计,需加强预防与治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prevalence estimates of atrial fibrillation (AF) from large populations have not been updated for >2 decades. Using data from 1996 to 1997, a previous study projected that there would be 3.3 million adults with AF in the United States in 2020. OBJECTIVES: The purpose of this study was to determine the contemporary age-, sex-, and race-standardized prevalence and the number of adults with diagnosed AF in the United States. METHODS: We merged California's state-wide health care databases to assemble a cohort of adults aged ≥20 years who received hospital-based care in California from 2005 to 2019. International Classification of Diseases codes were used to identify AF and other comorbidities. After accounting for deaths, we utilized the U.S. Census to calculate the national age-, sex-, and race-standardized estimates of diagnosed AF. RESULTS: Of 29,250,310 patients (mean age 50.6 ± 19.8 years, 53.8% women, 50.1% White), 2,003,867 (6.8%) had an AF diagnosis. The proportion of patients with diagnosed AF increased from 4.49% in 2005 to 2009 to 6.82% in 2015 to 2019. Over time, AF patients became relatively younger, were less likely to be female or White, and were more likely to have hypertension and diabetes. Standardizing based on age-, sex-, race-, and ethnicity-based proportions to the U.S. population, we estimate that the current national prevalence of diagnosed AF is at least 10.55 million (95% CI: 10.48-10.62 million), comprising 4.48% (95% CI: 4.47%-4.49%) of the adult population. CONCLUSIONS: The prevalence of diagnosed AF in the United States is higher than previously estimated. More efficient prevention and treatment strategies are needed to curb the burden of AF in the United States.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Noubiap JJ, Tang JJ, Teraoka JT, et al. Minimum National Prevalence of Diagnosed Atrial Fibrillation Inferred From California Acute Care Facilities. J Am Coll Cardiol. 2024. PMID: 39269390. doi:10.1016/j.jacc.2024.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。